Sylics offers innovative research solutions for preclinical neuroscience. We specialize in developing and employing customized mouse models and behavioural tests for neurological and psychiatric diseases, with a strong focus on neurodegeneration and schizophrenia. Highly efficient, sensitive and reproducible screening for behavioural deficits is supported by our automated screening platform and proprietary analysis software AHCODA™. Since 2007, the company characterized dozens of novel mouse models, and determined compound efficacy and side-effects in numerous projects for academia, biotech, and food industry clients.